Back to top
more

Danaher (DHR)

(Real Time Quote from BATS)

$269.18 USD

269.18
36,101

+0.37 (0.14%)

Updated Oct 9, 2024 09:56 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value F Growth D Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 42% (105 out of 252)

Industry: Diversified Operations

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

The Zacks Analyst Blog Highlights: CoreLogic, AutoNation, Danaher and NextEra Energy

by Zacks Equity Research

The Zacks Analyst Blog Highlights: CoreLogic, AutoNation, Danaher and NextEra Energy

Danaher (DHR) Q2 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Danaher (DHR) delivered earnings and revenue surprises of 35.85% and 6.74%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Tracey Ryniec headshot

5 Trendy Earnings Charts to Watch

by Tracey Ryniec

It's not all about tech companies. These 5 are in hot industries and have intriguing earnings charts.

The Zacks Analyst Blog Highlights: Bank of America, Abbott Laboratories, Chevron, Danaher and GlaxoSmithKline

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Bank of America, Abbott Laboratories, Chevron, Danaher and GlaxoSmithKline

Carlisle (CSL) Q2 Earnings & Revenues Surpass Estimates

by Zacks Equity Research

Carlisle's (CSL) Q2 revenues decline 22.1% year over year, owing to lackluster performance across all of its segments on a decline in sales volume due to the coronavirus outbreak-led issues.

Honeywell (HON) to Report Q2 Earnings: What's in the Offing?

by Zacks Equity Research

Honeywell (HON) is expected to have gained from its efforts to maximize productivity and a surge in demand for healthcare products. The pandemic-led issues will likely get reflected in its Q2 results.

Nalak Das headshot

4 Must-Buy Stocks Poised to Beat on Q2 Earnings This Week

by Nalak Das

Despite this gloomy scenario, there are a handful of stocks with a favorable Zacks Rank set to beat on earnings estimates this week.

Danaher (DHR) Upgraded to Buy: What Does It Mean for the Stock?

by Zacks Equity Research

Danaher (DHR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Will Danaher (DHR) Keep Its Earnings Streak Alive in Q2?

by Zacks Equity Research

Danaher's (DHR) Q2 results are anticipated to reflect healthy demand for some of its products and synergistic gains from Cytiva. Yet, subdued demand for a few other products is expected to have ailed.

Sheraz Mian headshot

Top Stock Reports for Bank of America, Abbott & Chevron

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including Bank of America (BAC), Abbott Laboratories (ABT) and Chevron (CVX).

Danaher (DHR) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

by Zacks Equity Research

Danaher (DHR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Is a Surprise Coming for Danaher (DHR) This Earnings Season?

by Zacks Equity Research

Danaher (DHR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Danaher (DHR) Expected to Beat Earnings Estimates: Should You Buy?

by Zacks Equity Research

Danaher (DHR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Can Danaher (DHR) Keep the Earnings Surprise Streak Alive?

by Zacks Equity Research

Danaher (DHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Danaher Shares Gain 26% in 3 Months: What's Driving the Rally?

by Zacks Equity Research

Danaher (DHR), with 26% growth in shares in the past three months, benefits from healthy demand for its products and synergistic benefits from acquired assets despite the pandemic-led woes.

When Does Market Timing Actually Work? - July 02, 2020

by Zacks Equity Research

Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?

Griffon to Pay Down Debts From Proceeds of Notes Offering

by Zacks Equity Research

Griffon (GFF) closes the offering of $150 million worth of senior notes. The proceeds will be used for redeeming notes due to expire in 2022, and pay for fees and expenses.

3M's (MMM) Sales Fall Y/Y in May on Lower Business Days

by Zacks Equity Research

3M's (MMM) weak sales performance in May gets affected by two lower business days. Also, the pandemic-induced uncertainties play spoilsport for segments and end-market businesses.

Yes, You Can Time the Market. Find out How - June 10, 2020

by Zacks Equity Research

Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?

Griffon (GFF) Prices $150M Worth of Senior Notes Offering

by Zacks Equity Research

Griffon (GFF) prices $150 million worth of senior notes offering. The proceeds will likely be used for redeeming notes due to expire in 2022, and pay for fees and expenses.

Danaher's (DHR) Product Offerings to Aid Amid Pandemic Scares

by Zacks Equity Research

Danaher's (DHR) risks from pandemic-related uncertainties are evident from weak sales projections for the second quarter. Demand for acute care diagnostics' related products might aid results.

Why Is Danaher (DHR) Up 3.3% Since Last Earnings Report?

by Zacks Equity Research

Danaher (DHR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Donaldson's (DCI) Prospects Bleak on Coronavirus Scares

by Zacks Equity Research

Donaldson (DCI) suffers from the adverse impacts of the pandemic and keeps the projections suspended for fiscal 2020. Forex woes and high leverage are also concerning.

3M's (MMM) Solid Product Portfolio to Aid Amid Pandemic

by Zacks Equity Research

3M (MMM) faces risks from the pandemic-related uncertainties, evident from a sales decline in April. However, cost-reduction measures and huge demand for respirators will likely support results in the second quarter.

General Electric to Divest Lighting Business, Shares Rise

by Zacks Equity Research

General Electric's (GE) divestment of the lighting business to Savant Systems will help it progress on its efforts to transform into an industrial company.